Effective delivery of siRNA (small interfering RNA) into the cells requires the translocation of siRNA into the cytosol. One potential delivery strategy uses cell-delivery peptides that facilitate this step. In the present paper, we describe the characterization of an amphipathic peptide that mediates the uptake of non-covalently bound siRNA into cells and its subsequent release into the cytosol. Biophysical characterization of peptide and peptide/siRNA mixtures at neutral and lysosomal (acidic) pH suggested the formation of α-helical structure only in endosomes and lysosomes. Surprisingly, even though the peptide enhanced the uptake of siRNA into cells, no direct interaction between siRNA and peptide was observed at neutral pH by isothermal titration calorimetry. Importantly, we show that peptide-mediated siRNA uptake occurred through endocytosis and, by applying novel endosomal-escape assays and cell-fractionation techniques, we demonstrated a pH-dependent alteration in endosome and lysosome integrity and subsequent release of siRNA and other cargo into the cytosol. These results indicate a peptide-mediated siRNA delivery through a pH-dependent and conformation-specific interaction with cellular membranes and not with the cargo.
Skip Nav Destination
Article navigation
April 2011
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
March 29 2011
Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape
René Bartz;
René Bartz
2
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
2Correspondence may be addressed to either of these authors (email [email protected] or [email protected]).
Search for other works by this author on:
Haihong Fan;
Haihong Fan
1
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
†Department of Pharmaceutical Sciences, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Jingtao Zhang;
Jingtao Zhang
1
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
†Department of Pharmaceutical Sciences, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Nathalie Innocent;
Nathalie Innocent
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Craig Cherrin;
Craig Cherrin
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Stephen C. Beck;
Stephen C. Beck
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Yi Pei;
Yi Pei
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Aaron Momose;
Aaron Momose
‡Department of Medicinal Chemistry, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Vasant Jadhav;
Vasant Jadhav
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
David M. Tellers;
David M. Tellers
‡Department of Medicinal Chemistry, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Fanyu Meng;
Fanyu Meng
§Department of Process Research, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Louis S. Crocker;
Louis S. Crocker
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
†Department of Pharmaceutical Sciences, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Laura Sepp-Lorenzino;
Laura Sepp-Lorenzino
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
Search for other works by this author on:
Stanley F. Barnett
Stanley F. Barnett
2
*Department of RNA Therapeutics, Merck & Co. Inc., 770 Sumneytown Pike, West Point, PA 19486, U.S.A.
2Correspondence may be addressed to either of these authors (email [email protected] or [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
July 08 2010
Revision Received:
November 10 2010
Accepted:
January 25 2011
Accepted Manuscript online:
January 25 2011
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2011 Biochemical Society
2011
Biochem J (2011) 435 (2): 475–487.
Article history
Received:
July 08 2010
Revision Received:
November 10 2010
Accepted:
January 25 2011
Accepted Manuscript online:
January 25 2011
Citation
René Bartz, Haihong Fan, Jingtao Zhang, Nathalie Innocent, Craig Cherrin, Stephen C. Beck, Yi Pei, Aaron Momose, Vasant Jadhav, David M. Tellers, Fanyu Meng, Louis S. Crocker, Laura Sepp-Lorenzino, Stanley F. Barnett; Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. Biochem J 15 April 2011; 435 (2): 475–487. doi: https://doi.org/10.1042/BJ20101021
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.